A carregar...
Pretargeted Radioimmunotherapy for Hematologic and Other Malignancies
Radioimmunotherapy (RIT) has emerged as one of the most promising treatment options, particularly for hematologic malignancies. However, this approach has generally been limited by a suboptimal therapeutic index (target-to-nontarget ratio) and an inability to deliver sufficient radiation doses to tu...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc.
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2936263/ https://ncbi.nlm.nih.gov/pubmed/20423225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2010.0759 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|